companydata.dkcompanydata.dk

Zerion Pharma A/S: Financial statements 2021

CVR: 40169229

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Zerion Pharma A/S (CVR 40169229) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 1,932,775 and a net result of DKK -11,134,049 compared with DKK -3,477,649 the year before. The profit margin was -576.1%. Equity in the 2021 report amounted to DKK -866,830. The company had 8 employees in the financial year.

Revenue
DKK 1,932,775
Gross Profit
DKK -6,714,675
Profit/Loss
DKK -11,134,049
Equity
DKK -866,830
Total Assets
DKK 13,697,624
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20211.9 mio.-6.7 mio.-11.1 mio.-867 t.8
2020-784 t.-3.5 mio.-1 mio.3
2019--1.1 mio.-1.1 mio.31 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Zerion Pharma A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Ole Sylvester-Hvid Wiborg leaves the board of Zerion Pharma A/SDec 27, 2021

As of December 27, 2021, Ole Sylvester-Hvid Wiborg has left the board of directors of Zerion Pharma A/S.

Zerion Pharma A/S appoints new auditorDec 14, 2021

As of December 14, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Zerion Pharma A/S.

Auditor steps down at Zerion Pharma A/SDec 14, 2021

As of December 14, 2021, BAAGØE SCHOU STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Zerion Pharma A/S.

Lars Lykke Thomsen joins the board of Zerion Pharma A/SDec 14, 2021

As of December 14, 2021, Lars Lykke Thomsen has joined the board of directors of Zerion Pharma A/S.

Dorte Juhl Arnbjerg joins the board of Zerion Pharma A/SDec 14, 2021

As of December 14, 2021, Dorte Juhl Arnbjerg has joined the board of directors of Zerion Pharma A/S.

Zerion Pharma ApS changes name to Zerion Pharma A/SDec 14, 2021

On December 14, 2021, the company changed its name from Zerion Pharma ApS to Zerion Pharma A/S.

Lars Lykke Thomsen leaves the board of Zerion Pharma A/SDec 13, 2021

As of December 13, 2021, Lars Lykke Thomsen has left the board of directors of Zerion Pharma A/S.

Torsten Rüdiger Goesch joins the board of Zerion Pharma A/SMay 12, 2021

As of May 12, 2021, Torsten Rüdiger Goesch has joined the board of directors of Zerion Pharma A/S.

Zerion Pharma A/S: The 2020 annual report is outMay 11, 2021

Zerion Pharma A/S has published its annual report for 2020. Gross profit came to DKK 784,282, and the net result was DKK -3,477,649.

Torsten Rüdiger Goesch leaves the board of Zerion Pharma A/SMay 11, 2021

As of May 11, 2021, Torsten Rüdiger Goesch has left the board of directors of Zerion Pharma A/S.

About Zerion Pharma A/S

Zerion Pharma A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Zerion Pharma ApS and Zerion ApS. The management consists of Ole Sylvester-Hvid Wiborg. The board consists of Carl-Åke Carlsson (chair), Geelanie Rodriguez Briones, Allan Stich and Dorte Juhl Arnbjerg. The company's owners include Geelanie Rodriguez Briones, WIBORG INTERNATIONAL HOLDING ApS and Waterman ApS. The company has 15 employees (2026). In 2025, the company reported revenue of DKK 3,377,646 and a net result of DKK -10,830,354 compared with DKK -220,020 the year before. Equity in the 2025 report amounted to DKK -3,511,410.

Source: annual report 2025, Danish Business Authority

Other financial years